My ePortfolio Register   

WIN 2016 /
WIN 2016 highlights: Changing the understanding of cancer

27th - 28th Jun 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.07.16
Views: 1272

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)

Prof Schilsky speaks with ecancertv at WIN 2016 about changing understandings of cancer aetiology and treatment.

He discusses the growing application of immunotherapy, including checkpoint inhibitors, but cautions against a rush to adopt combination therapy without considering the adaptability and resistance development of tumour cells.

Prof Schilsky also comments on the SHIVA trial, as discussed by Dr Kurzrock, and the need for consistent communication and sharing of standards between clinics to advance personalised cancer care.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence